BrainsWay Ltd.

BWAY
$14.13 (- $0.20 - 1.40%)
Last updated: 2026-06-17 07:45 UTC
BWAY Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS10501L1061
CUSIP10501L106
Market Price14.13
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio60.53
EPS0.32
Market Cap$379.2M
Book Value1.79
Price to Book10.821
Beta0.27
52w High19.8
52w Low7.84
Next Earnings DateN/A

BrainsWay Ltd. trades under ticker BWAY on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US10501L1061, CUSIP 10501L106.

About the Company
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Price History